What are you looking for?
top

KESIMPTA®▼(ofatumumab) downloadable resources

KESIMPTA is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis with active disease defined by clinical or imaging features.1

This selection of resources is designed for healthcare professionals to support patients with relapsing forms of multiple sclerosis (RMS) throughout their KESIMPTA journey.

You can download these materials and share them with your healthcare team. There is a separate tab for resources which can be shared with patients. Please do not share this web page with patients; instead, please direct them to the patient portal where they can access these resources.

Preview image. GB KESIMPTA Demonstration Pen Kit.

KESIMPTA DEMONSTRATION 
PEN KIT

PDF
Download
Preview image. GB Treatment Initiation Checklist.

TREATMENT INITIATION CHECKLIST

PDF
Download
Preview image. 'Getting to know KESIMPTA®▼ Patient Welcome Booklet.

PATIENT WELCOME BOOKLET

PDF
Download

Reference

  1. KESIMPTA (ofatumumab) Summary of Product Characteristics.

Green vertical divider icon
 Safety profile

UK | January 2025 | 443408

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.